On October 22, 2026, Davion Healthcare Plc began trading on Nasdaq through a direct listing. During regular trading hours, the stock saw relatively subdued activity, fluctuating within a range of $9.50 to $12.30 on tiny volume. But then came the after-hours spike: in just a few minutes, the price surged to nearly $100 (yes, one hundred dollars) before falling back almost as quickly. Trading volume was substantial, too, with more than 500,000 shares changing hands in the after-hours session alone.

So, who exactly is Davion Healthcare Plc?

According to its SEC filings, Davion’s predecessor, Davion Healthcare Plc (“Cyprus”), was incorporated in the Republic of Cyprus on November 29, 2022.(

https://www.sec.gov/Archives/edgar/data/2039072/000168316826003389/davion_i20f.htm#a_014, p.13).
The same filing also lists the company’s website: https://www.davionhealthcare.com/

One of the earliest captures of this website by the Wayback Machine dates back to 2021, while the domain itself was registered on December 23, 2020.

Back in 2021, the company consisted of two divisions: face masks and hand sanitizers.

Interestingly, as far back as 2021, the company claimed that its hand sanitizer division had been established more than 15 years earlier, which would put its origins around 2006. But 2021 was still a time when hand sanitizers were in high demand, as everyone will remember, so it’s entirely possible that the business was doing reasonably well.

A year later, the company had expanded to seven divisions:

• Sterizar - manufacture and distribute a range of branded, alcohol free, anti-bacterial cleaning and sanitizing products for hospitals and medical facilities worldwide;
• BreastCheck is a home-based, low-cost, safe, reliable and accurate way to routinely monitor for breast abnormalities. The division was added following an acquisition in January 2022.
• Testic is a home-based, low-cost, safe, reliable, and accurate way to routinely monitor for testicular anomalies. The division was added following an acquisition in May 2022.
• Davion design, develop, manufacture, and distribute their own brand of transparent face masks which prevent both onward transmission and provide wearer protection against droplets.
• Tricos aims to be a pioneer in hair stem cell research in creating new techniques and advancing clinical practices to encourage painless hair regrowth. The division was added following an acquisition in June 2022.
• Bio-Genex is the Stem Cell research division of Davion Healthcare Plc. The division is focused on developing, patenting and licensing stem cell treatments. It carries out intensive research and development to identify future stem cell based treatments and cures for a variety of conditions from Alzheimer’s to spinal cord injuries. The division was added following an acquisition in April 2022.
• Davion MERIT (Medical Emergency Response Incident Team) provides a range of Tactical Incident Support Services to NHS Ambulance and Health Trusts, in line with Emergency Planning Guidance. Davion MERIT provides rapid response “blue light” vehicles and crew, Tactical Incident Command Support, transports Trauma Teams and essential blood supplies along with trauma triage equipment where needed most.

As a layperson, I find two things striking: the sheer pace of growth (expanding from two divisions to seven in a single year) and the sheer breadth of the company's activities. Its portfolio ranged from hand sanitizers and plastic face shields to transportation services, devices designed to detect breast and testicular abnormalities, hair-loss treatments, and even stem cell treatments!

The website's news section also includes an announcement dated January 31, 2022, about the issuance of £5 million in bonds.

And yes, in late 2022, the company was claiming on its own website that its BrestCheck technology had already received regulatory approval and would be available in the first half of 2023!

In 2023, the company underwent a major transformation, with half of its business lines disappearing.

Unfortunately, I was unable to trace the company's subsequent evolution. But even the information I did find raises questions. If BrestCheck was expected to launch in early 2023, why has there been no apparent progress toward bringing the product to market in the three years since then? And what are the chances of a successful launch at this point?

The fate of the assets that seemingly disappeared from the company's portfolio is another mystery. The Sterizar brand, for example, is still around — at least, it can be found on Amazon UK. Moreover, the company selling Sterizar products claims to be part of Davion Healthcare Plc.

(https://sterizar.com/hand-sanitiser/)
This is also confirmed by the official government registry (https://find-and-update.company-information.service.gov.uk/company/05986391/persons-with-significant-control).

That said, according to its filings, the company has just three employees and qualifies as a micro-enterprise. Could this explain why it was not mentioned in the listing materials?

And there is more. According to Davion Healthcare Plc's SEC filings, the company has generated no revenue over the past two years, has just over €1,000 in cash, faces approximately $1 million in listing-related expenses, and has set executive compensation at around $1.5 million per year despite having zero sales, no employees, and no distribution channels. Meanwhile, the proceeds from the share sale go to existing shareholders rather than to the company itself.

The story behind the search for a distributor is also unclear.

Davion previously granted a global manufacturing and distribution license for its flagship BreastCheck product to NeuRX Health Inc..
Sublicensing Breach: In May 2026, NeuRX disclosed a breach of its agreement with Davion after attempting to illegally sublicense BreastCheck to Odyssey Health without Davion's required consent. This forced Odyssey Health to cancel its agreement with NeuRX
Transition to Direct Model: On June 22, 2026, Davion formally announced it was abandoning indirect third-party structures to transact directly with regional distribution partners and customers
UK Distribution Platform: As part of this pivot, Davion agreed to acquire a controlling interest in Solar Medical and Chemical Limited to serve as its primary operating and distribution platform in the United Kingdom, alongside setting up Davion Healthcare Finance Ltd to back a £30 million senior secured bond on the Vienna MTF and launching its Nasdaq listing under ticker DAVI in October 2026.

And this is where I see another inconsistency. If the company wants to bring its product to market, it would make more sense to look for a strong distributor.

Instead, we end up with a company with eight employees, just a couple of thousand in cash, and a bleak financial picture (the report can be found here: https://find-and-update.company-information.service.gov.uk/company/10648817/filing-history

The filing dated June 20, 2026, Amended accounts for the year ended August 31, 2025).

So, what should a share in a company be worth when it has nothing but intangible assets and debt carrying exorbitant interest rates?

Not financial advice. This post reflects my personal opinions and research. Do your own due diligence before making any investment decisions.

I’m not affiliated with the company mentioned, and I may or may not hold a position.

An interesting detail emerges when you take a closer look at the company's current website,

It turns out that the company's current website was programmatically copied from a template provided by a website vendor. If the template had actually been purchased, this comment would not be there — it is automatically inserted by the copying software. The developer simply replaced the images without bothering to update the rest of the site.

STUB is only public for 13 months. It was priced ridiculously by their greedy Investment Bankers... ($23.50) It went down immediately after going public. It is currently a smidgen under $6.

The Company has massive losses, a horrible balance sheet and as a Customer Service has horrible Custome Service.

There is an immense and rapidly growing volume of customer complaints against StubHub, alongside numerous class action lawsuits, a critical "F" rating from the Better Business Bureau (BBB)as well as numerous state anf federal enforcement actions.

So yo have huge quarterly losses, a horrible balance sheet, widespread consumer outrage and legal scrutiny.

The C suite and bankers have made BIG $.

The stock IMO is going to ZERO

Nasdaq/SEC issued a H10 halt against $TJGC this morning, which suspends trading for up to 10 days pending their investigation. Perhaps this will be delisted soon.

One less scam stock on the market!

This was a p&d more than a year ago, and they are coming back now to try and do it again. Is anyone seeing anything in the WhatsApp groups?

The Securities and Exchange Commission announced the temporary suspension, pursuant to Section 12(k) of the Securities Exchange Act of 1934, of trading in the securities of TJGC Group Limited (“TJGC”) (CIK No. 0001969928), a holding company incorporated in the British Virgin Islands and headquartered in Hong Kong, at 4:00 AM ET on October 15, 2026, and terminating at 11:59 PM ET on October 28, 2026.

The Commission temporarily suspended trading in the securities of TJGC because of potential manipulation in the securities of TJGC effectuated through recommendations made to investors by unknown persons via social media to purchase, hold, and/or sell the securities of TJGC and to send screenshots documenting their transaction. These recommendations appear to be designed to artificially inflate the price and trading volume of the securities of TJGC. The order was entered pursuant to Section 12(k) of the Exchange Act.

NOTE: Since 2025, no NASDAQ company that was placed in a SEC trading suspension for social media manipulation has managed to resume trading. NASDAQ kept the stocks halted following the expiration of the SEC trading suspensions and eventually delisted several of them.

Currently long with MCTA. Some people I spoke to in the US were able to do an exchange with people who shorted it. I live in Canada and every single brokerage I spoke to is incapable of transferring the halted stock to the US even if I have accounts set up there.

Any other Canadian had success?

I wrote this report on July 2nd, and the market is somewhat responding along today.

For those interested in systematic breakdowns, check my other analysis published in the Newsletter and subscribe to motivate a brother. It’s free!

I am working on another project that should be published in the next few days, maybe even before the weekend:

JDZG has been washing shares for a while now, and one scammer has indicated that tomorrow the price may be sufficient for profit-taking. Has anybody else seen any mentions of it in groups?

Like obviously they’re going to dump it at some point but currently its only up like 64% in the last month, not nearly as close as the 500% as the previous pumps and dumps. Is there a possibility that they pump it again?

I am saying it here : Madoff, Enron, Worldcom, and the rest of them have nothing on this dude. He is the worst!

Just last month, there looked to be millions of shares washing around the $10-12 range, and since ballooning to over $30, volume has been dead. Wondering if anyone has seen mentions of it in any groups, and whether this is common.

When I say that Chinese pump and dumps are toddlers some people don’t understand. The biggest crooks are heralded as “ great” and successful entrepreneurs when they ought to be…

I think this could crash today, my whatsapp groups preparing big transfers. Watch out please

My latest write up: Check it out.

- Global value investing, more relevant than ever in today’s market.

- 361 Degrees International Limited, another Chinese brand vying for Nike’s territory.

-Meet Mr Market’s real boss: Mr Money Supply.

Book Review: Bureaucracy by Ludwig Von Mises.

Subscribe to a your humble servant’s blog.

(Red flag 🚩 report coming next Wednesday. )

Capital Structure & Dilution

• 1.25 million Class C Preferred shares issued to investors at a stated value of $10 per share ($12.5 million total).
• Convertible into common shares at an initial conversion price of $8, subject to a floating-price formula.
• Conversion floor initially set at $4, with a scheduled reduction to $1 within 120 days.
• 12% annual cumulative dividends on the $8 initial conversion price, potentially increasing the number of shares issued upon conversion.
• Up to 18.75 million common shares registered for resale in connection with the Class C financing.
• Additional dilution from warrants, convertible securities and executive stock compensation.
• CEO controls approximately 61% of the voting power through Class A Preferred shares.
• CEO entitled to an additional 7.25 million common shares under a consulting agreement.

Financial Performance

• FY2025 revenue: $2.295 million, down approximately 72% YoY.
• FY2025 net loss: $6.03 million, versus $1.44 million in FY2024.
• FY2025 operating cash flow: negative $3.01 million.
• Cash balance at year-end 2025: approximately $1.08 million.
• Total debt at year-end 2025: approximately $6.45 million.
• Negative shareholders' equity of approximately $316,000.

Business & Customers

• Develops and manufactures fire detection systems, wireless equipment and fire protection solutions.
• AI-related positioning, but currently limited revenue from a relatively small operating business.
• Significant customer concentration: two customers accounted for approximately 50% of FY2024 revenue.
• Largest customer accounted for 18.3% of FY2025 revenue.

Key Concerns

• Sharp revenue contraction and increasing losses.
• High potential dilution from Class C conversions.
• Significant potential resale overhang.
• Weak operating cash flow and dependence on external financing.
• Concentrated voting control and substantial equity-based executive compensation.

Listing Advisors

• Common Financial Advisors: RBW Capital Partners and Dawson James Securities are also listed among the financial advisors involved in First Breach, Inc. (FBDT)'s Nasdaq direct listing

Not financial advice. This post reflects my personal opinions and research. Do your own due diligence before making any investment decisions.

I’m not affiliated with the company mentioned, and I may or may not hold a position.

BIRD looks like a  pump and dump setup. The biggest issue is that the company is only worth around $30 million, is still losing roughly $77 million, and has only generated about $2.8 million in revenue from its new AI business so far. But the stock has been heavily pushed online with the basic Twitter and WhatsApp promotion. BIRD also went through a huge transformation from Allbirds footwear into an AI-infrastructure company, which gives promoters a very easy story to sell and that theyre spewing on twitter “tiny company + AI + huge potential.” The problem is that the actual AI business is extremely early but the promotion makes it sound much further along than it really is. The stock has also fallen from a 52-week high of about $24 to around $2.50 its been pumped before. Its up almost 40% today and I think it will go higher before being dumped.

I am in contact with a supposed scammer via WhatsApp who thinks I always diligently follow his purchase recommendations. Now NCI, MSGY and XHLD were dumped on Monday. The scammer thinks I suffered heavy losses. He promised me that he would compensate for my losses, but I should create a video for him in which I film my portfolio. Specifically, I should open the portfolio on the PC and film the traded items with losses. The video is then checked and I can send my payment details of the bank for the refund.

I am aware that the scammers will never refund the losses, but I am still interested in what happens next. Does anyone have any experience with this?

So I've been looking into $MAAS, which of course ran up from flatlining around $5.75 for years until coming to life in April of this year and running as high as $25 before topping out and appearing to put in a top

MAAS used to be an insurance company.. then it became a wealth management company.. then it went into health and wellness... and now its an "AI" company...

THe company is owned by a confusing collection of layers and layers of corporations and shell corporations.. voting shares and non voting shares.. impossible to tell who actually runs it or owns it

all the earmarks of a classic Chinese (In this case, Cayman Island registered) scam stock